• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Corynebacterium Infections

Corynebacterium Infections - 25 Studies Found

Active, not recruiting : Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features
: Corynebacterium Infections
: 2017-03-09
Not yet recruiting : Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
: Heterologous Effects of Vaccines
: 2016-05-03
:
  • Biological: Seasonal influenza vaccine

Completed : A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
: Diphtheria
: 2016-04-28
: Biological: Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)]
Completed : Duration of Protection: GSK DTaP Vaccines
:
  • Diphtheria
  • Acellular Pertussis
  • Tetanus

: 2015-03-26
:
  • Biological: Infanrix Diphtheri

Completed : Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
: Diphtheria-Tetanus-acellular Pertussis Vaccines
: 2015-02-26
:
  • Biological: Boostrix™ On

Completed : Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
:
  • Diphtheria
  • Tetanus
  • Acellular Pertussis

: 2013-11-14
: Biological: Boostrix™ Single-dose administered intramuscularly in the deltoid region of non-domina
Completed : Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
:
  • Tetanus
  • Acellular Pertussis
  • Diphtheria

: 2012-11-21
: Biological: Boostrix Single dose intramuscular administration.
Completed : Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria
  • Biological: Infanrix+Hib™

Completed : Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
:
  • Diphtheria
  • Tetanus
  • Acellular Pertussis

: 2011-05-19
:
  • Biological: Boostrix TM (new syringe presentation)

Completed : Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

: 2011-02-10
:
  • Biological: Boostrix™ (dTpa)

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.